FEATURED ARTICLES
The Promise Of Bispecifics In The Quest For Outpatient Immunotherapy
START San Antonio's Drew Rasco, MD, reflects on the evolution of immunotherapy and highlights how novel therapies such as bispecifics are both challenging and intriguing for principal investigators (PIs).
-
How Clinical Research Site Operating Models Perform in Practice – Part 2
In part two of this three-part series, Paradigm Clinical Research CEO Kurt Mussina evaluates how each site operating model performs regarding speed, patient access, investigator engagement, quality, accountability, and scalability.
-
Why Operating Model Is The Next Competitive Frontier In Clinical Research Site Strategy – Part 1
In this three-part series, Paradigm Clinical Research CEO Kurt Mussina discusses the meaningfulness of a site's operating model to clinical trial sponsors. In part one, he first defines operating model types.
-
What Sponsors Don't See: The Systems Behind Clinical Trial Delivery
What do sponsors need from sites? Easy. How do they evaluate them? Not so easy (or accurate). In this column, Association Multisite Research Corporations (AMRC) Executive Director Jim Kremidas explains how sites and sponsors can make site evaluations better.